![Theranos In Court: Balwani Lawyers Dealt Another Blow](https://www.g2intelligence.com/wp-content/uploads/2022/06/June20-2022.News_.BalwaniTrial-iStock-1800x1250-1-1080x675.jpg)
Theranos In Court: Balwani Lawyers Dealt Another Blow
Move to exclude testimony regarding potential patient impact of lab deficiencies as hearsay is dismissed by the court.
Move to exclude testimony regarding potential patient impact of lab deficiencies as hearsay is dismissed by the court.
Three labs, their owner, two lab marketing companies, a fourth lab, and a physician are accused of kickbacks, money laundering, and fraud.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.
Settlements for False Claims Act allegations the theme in recent enforcement actions involving the healthcare industry.